Description
BSE lists Rs. 250 crore Commercial Paper issued by Manappuram Finance Limited with maturity date of September 15, 2026.
Summary
BSE has listed new Commercial Paper issued by Manappuram Finance Limited on private placement basis. The instrument comprises 5,000 units of Rs. 5,00,000 each (total Rs. 250 crore) with allotment date of November 6, 2025 and redemption date of September 15, 2026. The securities will be traded in dematerialized form on the BSE Debt segment.
Key Points
- Issuer: Manappuram Finance Limited
- Instrument Type: Commercial Paper (private placement)
- Face Value: Rs. 5,00,000 per unit
- Issue Price: Rs. 4,69,407.50 per unit
- Total Quantity: 5,000 units (Rs. 250 crore)
- Scrip Code: 730514
- Scrip ID: MFL061125
- ISIN: INE522D14OU1
- Credit Rating: CARE A1+, CRISIL A1+
- Market Lot: 1 unit
- Trading Mode: Dematerialized only
- Issuing and Paying Agent: AXS BANK
Regulatory Changes
No regulatory changes. This is a routine listing notification.
Compliance Requirements
- Trading members must trade these securities only in dematerialized form under ISIN INE522D14OU1
- Trading shall take place in standard denomination of Rs. 5 lakhs and multiples thereof
- Tick size for the securities is 1 paise
- Trading members requiring clarification should contact BSE debt department at 22728352/8597/8995/5753/8915
Important Dates
- Notice Date: November 7, 2025
- Allotment Date: November 6, 2025
- Listing Date: November 7, 2025
- Redemption Date: September 15, 2026
- Tenure: Approximately 10 months
Impact Assessment
Market Impact: Minimal. This is a routine commercial paper listing with no impact on equity markets or broader market operations.
Operational Impact: Limited to debt market participants and investors interested in short-term debt instruments of Manappuram Finance Limited.
Investor Relevance: The instrument carries dual A1+ ratings from CARE and CRISIL, indicating high credit quality. The discount to face value (issue price Rs. 4,69,407.50 vs face value Rs. 5,00,000) provides implicit yield for investors over the 10-month tenure.
Impact Justification
Routine commercial paper listing with no market-wide impact, relevant only to debt market participants and the issuer